Fulgent Genetics (FLGT) Net Income towards Common Stockholders Growth (3y) (2018 - 2026)
Powered by 
Analysis
Fulgent Genetics (FLGT) Net Income towards Common Stockholders Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 15.47% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 10.22% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 16.51% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -18.19% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 28.59% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 31.64% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 30.27% |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | -38.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -38.03% |
| Mar 31, 2026 | -17.41% |
| Dec 31, 2025 | 0.92% |
| Sep 30, 2025 | -90.56% |
| Jun 30, 2025 | -54.88% |
| Mar 31, 2025 | -27.55% |
| Dec 31, 2024 | -27.17% |
| Sep 30, 2024 | -28.46% |
| Jun 30, 2024 | -28.36% |
| Mar 31, 2024 | -27.39% |
| Dec 31, 2023 | -40.32% |
| Sep 30, 2023 | -31.33% |
| Jun 30, 2023 | -73.20% |
| Mar 31, 2023 | -107.90% |
| Dec 31, 2022 | -482.20% |
| Sep 30, 2022 | -6.39% |
| Jun 30, 2022 | 184.49% |
| Mar 31, 2022 | 358.31% |
| Dec 31, 2021 | 289.29% |
| Sep 30, 2021 | 583.61% |